TD Cowen initiates coverage of Adarx Pharmaceuticals with buy rating
ADRX•TD Cowen initiated coverage of Adarx Pharmaceuticals with a buy rating.
Related News
Newmont: TD Cowen cuts target price to $131 from $133
NEM•
As Japan pursues a chip-industry reboot, it's being pressed to build America's chip industry
GFS•
Daiwa, Mizuho reportedly poised to launch China securities units after clearing final hurdles
MFG•
North Sea gas maintenance schedule revises Rough outage
UNG•
Alamos Gold Inc.: TD Cowen cuts target price to C$53.00 from C$54.00
AGI•